Le Lézard
Classified in: Health, Science and technology
Subject: PLW

Medac Pharma, Inc. Announces The Patent Trial And Appeal Board (PTAB) Upheld Patents On Rasuvo® (Single Dose Auto-Injection Of Methotrexate)


CHICAGO, Feb. 9, 2018 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company, today announced the PTAB has upheld all 22 claims of our parent company medac GmbH's patent covering its rheumatoid arthritis treatment, Rasuvo®, an auto-injector that provides highly concentrated doses of methotrexate.  This ruling ends the challenge brought by Koios Pharmaceuticals LLC.

"Medac is gratified by the PTAB decision upholding the patentability of all the claims of its '231 patent," stated Medac's CEO Terri Shoemaker. "The patent, which is based on Medac's pioneering work to bring methotrexate treatment to patients in need of safe, less painful, and easy to use form, does not expire until 2029.

About Medac Pharma

Medac Pharma, Inc. is a privately held specialty pharmaceutical company focused on the development, in-licensing and commercialization of late-stage molecules.  The company strives to bring new life to products and solve everyday patient challenges in autoimmune disease and cancer.  For more information about Medac Pharma, please visit www.medacpharma.com

Medac Pharma is the wholly-owned subsidiary of medac GmbH, a well-known and respected global pharmaceutical company that has been making scientific and therapeutic discoveries for more than 40 years.  For more information about medac GmbH, please visit www.medac.de 

For complete prescribing information, including Boxed Warning, and information on Medac Pharma's CORE Connections program, please visit www.Rasuvo.com

Medac Media Contact:

Tiberend Strategic Advisors, Inc.
David Schemelia
212-375-2686
[email protected]

SOURCE Medac Pharma, Inc.


These press releases may also interest you

at 17:41
/DISREGARD RELEASE: FirstHive/
We are advised by a representative for FirstHive that journalists and other readers should disregard the news release, FirstHive Welcomes Investors Benhamou Global Ventures, Saama and Amit Singal in New Funding Round, issued April 24, 2024 over PR...

at 17:30
Pluribus Technologies Corp. Announces Details of Q4 2023 Financial Results Conference Call
Pluribus Technologies Corp. ("Pluribus" or the "Company"), a growing acquirer of small, profitable technology companies, today announced that Company management will host a conference call to discuss its fiscal 2024 fourth quarter financial results...

at 17:00
SpryPoint Unveils Embedded Payment Solution for SpryCIS and SpryEngage Platforms
SpryPoint, the leading enterprise software-as-a-service (SaaS) provider to Utilities across North America, is proud to announce the upcoming release of SpryWallet, an embedded payment solution designed specifically for the SpryCIS and SpryEngage...

at 16:55
Veterinary Management Groups (VMG) Launches Innovative Veterinary Economic Dashboard
Veterinary Management Groups (VMG) is proud to...

at 16:53
Celebrating Connectivity: telMAX brings Canada's Fastest Internet to The City of Richmond Hill.
telMAX broke ground today in Richmond Hill with the commencement of a state-of-the-art fibre Internet infrastructure project that will deliver all-fibre Internet connectivity to residents and businesses throughout the community....

at 16:35
Bragg Announces US$7 Million Secured Note Financing
Bragg Gaming Group Inc. ("Bragg" or the "Company"), a global B2B gaming technology and content provider, today announced the issuance of a secured promissory note in the principal amount of US$7 million (the "Note") to certain entities controlled by...

More news about Science and technology...


News published on and distributed by: